Iodine Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Iodine dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Iodine.
Dosing Protocols
The Beginner Protocol ensures iodine adequacy for the general population without tipping into risk territory. If you use iodized salt regularly in home cooking and eat any seafood or dairy, you likely meet the 150 mcg/day RDA from food alone and do not need supplementation. Target 150 mcg/day total from food plus (if needed) a multivitamin containing 100–150 mcg iodine as potassium iodide or kelp. Avoid "trace mineral" products that provide only tiny amounts (20–50 mcg) if you are supplementing specifically for iodine in pregnancy or known inadequate diet. For pregnancy, shift to 220 mcg/day total intake by ensuring your prenatal vitamin contains 150 mcg iodine (many commonly-prescribed prenatals do not — check the label) and consuming iodized salt and dairy; this is one of the most important nutrient considerations in pregnancy given the irreversible neurodevelopmental consequences of deficiency in offspring (PMID 23706508, 28056690). For lactation, 290 mcg/day via the same approach. Avoid sea vegetable products (kelp, kombu, nori supplements) in pregnancy — iodine content varies dramatically batch-to-batch and some products deliver milligram doses of iodine unsafely. The Beginner Protocol specifically does NOT include Lugol's, Iodoral, or SSKI supplementation: these are milligram-range products outside the appropriate window for routine use. If you are not pregnant, not deficient, not in a radiation emergency, and not under endocrinology supervision for a specific thyroid indication, the correct iodine dose is food-plus-multivitamin in the RDA range. Consider having an emergency potassium iodide (KI) supply if you live near a nuclear facility per FDA radiation emergency preparedness guidance — 130 mg tablets for adults, used only if instructed by public health authorities during an actual release.
The Intermediate Protocol addresses suspected iodine inadequacy confirmed by urinary iodine concentration or clear clinical suspicion, targeted at replenishment without tipping into excess. Begin with spot or 24-hour urinary iodine measurement: adult adequate ≥100 mcg/L, pregnancy adequate ≥150 mcg/L. If UIC is low and you have access to endocrinology or a thoughtful primary care clinician, supplement 150–300 mcg/day elemental iodine as potassium iodide (direct molecular form, best characterized) or kelp-derived product with standardized iodine content. Check TSH and free T4 at baseline before starting, particularly if there is any personal or family history of thyroid disease. Take with any meal; iodine absorption is not food-dependent. Duration 3–6 months with repeat UIC and TSH at 3 months — most patients normalize UIC quickly and can shift to RDA-range maintenance. If TSH rises into subclinical hypothyroid range during supplementation, this suggests underlying Hashimoto susceptibility and warrants stopping iodine and obtaining thyroid antibodies (TPO, TgAb). If TSH falls into subclinical hyperthyroid range, particularly with any multinodular goiter history, stop iodine and refer to endocrinology for evaluation of autonomous nodules. Pair with selenium 100–200 mcg/day (selenomethionine) throughout, and ensure adequate zinc, iron, and vitamin D status — the cofactor picture matters as much as the iodine itself. For suspected iodine deficiency without UIC testing available, a two-month trial of 150 mcg/day (matching a pregnancy prenatal dose) is low-risk for most adults and can be assessed clinically for thyroid symptom response, though this is a rougher approach than lab-guided repletion. Do not escalate above 300 mcg/day without endocrinology guidance.
The Advanced Protocol covers specific clinical indications for pharmacologic iodine dosing: preoperative Graves disease preparation (SSKI or Lugol's used short-term to reduce thyroid vascularity and acute hormone release, typically 5 drops SSKI three times daily for 10 days before thyroidectomy, under endocrinology direction), thyroid storm management (high-dose iodine with methimazole/PTU in ICU settings), radiation emergency prophylaxis (potassium iodide 130 mg for adults, 65 mg for children 3–18, dosing varies by age; used only when instructed by public health authorities during actual radioactive iodine release), and the highly contested high-dose iodine protocols advocated by Abraham, Brownstein, and others (12.5–50 mg daily Lugol's or Iodoral) for fibrocystic breast disease, breast cancer risk reduction, or general "iodine sufficiency" goals. The high-dose iodine subculture is not supported by rigorous clinical trial evidence and has clear documented risks: iodine-induced hyperthyroidism (Jod-Basedow phenomenon, especially in older adults with autonomous nodules), iodine-induced hypothyroidism in Hashimoto-susceptible patients, and acceleration of underlying autoimmune thyroid disease. If you are considering high-dose iodine for any reason, the Advanced Protocol is: get baseline TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies, thyroid ultrasound if any goiter or nodules; work with an endocrinologist or thyroidologist rather than alone; start at the lowest dose of any extended protocol and escalate only with monitoring; recheck thyroid function at 4–8 weeks and at 3 months; stop at any sign of palpitations, tremor, heat intolerance, unintended weight loss, new-onset fatigue or cold intolerance; and recognize that the evidence base does not support long-term high-dose iodine for the indications typically claimed. For the radioiodine-ablation or scintigraphy prep context, a low-iodine diet (LID, <50 mcg/day) is prescribed for 2–4 weeks prior, specifically avoiding iodized salt, dairy, seafood, seaweed, eggs, commercial bread, and iodine-containing supplements — this is effectively the opposite of a supplementation protocol and is specialist-directed for specific therapeutic contexts. The Advanced principle for iodine mirrors other narrow-therapeutic-window nutrients: the indications for supra-RDA dosing are specific and rare in general population practice, and self-directed high-dose iodine without endocrinology involvement carries real and documented thyroid risks.
Commonly Stacked With
Iodine's stacking logic is dominated by its partnership with Selenium — the two minerals are obligate partners in thyroid biology and a coherent thyroid-support protocol addresses both. Selenium-dependent deiodinases (D1, D2, D3) convert T4 to active T3 in peripheral tissues, and selenium-dependent glutathione peroxidase protects the thyroid gland from the oxidative stress of hormone synthesis. Iodine repletion in the absence of adequate selenium produces impaired peripheral T3 generation; selenium supplementation in iodine-deficient regions has been associated with worsening hypothyroidism as more iodine is shuttled toward storage and less toward hormone output. The practical stacking rule: iodine and selenium should be addressed together, with selenium 100–200 mcg/day (typically as selenomethionine) paired with iodine 150–300 mcg/day (as potassium iodide or kelp) for general thyroid support. Do not supplement iodine without addressing selenium status, especially in pregnancy where both matter for fetal neurodevelopment. Iodine and Zinc: zinc is a cofactor for the TSH-releasing hormone receptor and contributes to pituitary-thyroid axis integrity, and mild zinc deficiency has been associated with subclinical hypothyroidism in some studies. Standard RDA-range zinc (10–15 mg/day) supports thyroid function without interfering with iodine. Iodine and Vitamin D: vitamin D sufficiency has been associated with lower rates of Hashimoto thyroiditis, and vitamin D is a reasonable adjunct in any thyroid-support stack. Iodine and iron: iron-deficiency anemia impairs thyroid peroxidase activity (TPO is a hemoprotein), and correcting iron deficiency improves response to iodine supplementation in deficient populations — iron and iodine co-deficiency is a particular concern in pregnancy and in adolescent girls. Iodine and Vitamin B12: the shared autoimmunity context matters — pernicious anemia (autoimmune B12 deficiency) frequently coexists with Hashimoto thyroiditis in polyglandular autoimmune syndrome, and patients with either condition should be screened for the other. There is no absorption or metabolic interference. Iodine and Alpha-Lipoic Acid: ALA has weak metal chelating activity and has been used in autoimmune thyroid disease without clear benefit or harm; standard doses (300–600 mg/day) do not meaningfully affect iodine status. Iodine and Vitamin C: vitamin C does not interfere with iodine, and in some contexts supports immune and antioxidant status alongside thyroid care. Iodine and CoQ10: no direct interaction, but both support mitochondrial function in the thyroid gland, and CoQ10 is a reasonable adjunct in subclinical hypothyroidism given the bioenergetic contributions of thyroid hormone. Iodine and thyroid hormone replacement (levothyroxine): patients on levothyroxine can generally continue normal dietary iodine intake (iodized salt, seafood, dairy) without concern, but should avoid high-dose iodine supplements without endocrinology input — excess iodine can destabilize dose titration and worsen underlying autoimmune thyroid disease. Iodine and methimazole/PTU (antithyroid drugs for Graves disease): avoid supplemental iodine during antithyroid drug therapy; iodine substrate availability directly opposes the drug mechanism. Iodine and lithium: lithium concentrates in thyroid and both suppress thyroid function in additive fashion; avoid supplemental iodine without psychiatry/endocrinology coordination in lithium-treated patients. Iodine and amiodarone: amiodarone is ~37% iodine by weight, and adding supplemental iodine on top risks tipping already-complex amiodarone-induced thyroid dysfunction; avoid without cardiology/endocrinology coordination. Iodine and radioiodine (I-123, I-131): all iodine sources including supplements, iodized salt, seafood, seaweed, and iodine-containing contrast must be stopped 2–4 weeks before scintigraphy or ablation. The practical stacking synthesis: selenium plus modest iodine plus zinc plus vitamin D plus adequate iron is the "thyroid support" foundation, with iodine kept in the 150–300 mcg/day range from food and low-dose supplementation rather than mg-range Lugol's/Iodoral unless there is a specific clinical indication under endocrinology supervision.
Side Effects & Safety
Contraindications
Iodine supplementation above the RDA is contraindicated or requires special caution in several clinical contexts. Active Graves hyperthyroidism is a relative contraindication for supplemental iodine (SSKI used preoperatively is specialist-directed, short-term, and aimed at thyroid gland reduction before surgery — not general supplementation). Autonomous thyroid nodules or multinodular goiter in older adults predispose to Jod-Basedow iodine-induced hyperthyroidism; iodine supplementation in these patients should be limited to RDA range and avoid Lugol's/Iodoral/SSKI forms without endocrinology evaluation. Known Hashimoto thyroiditis is a relative contraindication for high-dose iodine: multiple case series document worsening autoimmunity, rising TPO antibodies, and progression to overt hypothyroidism in Hashimoto patients exposed to mg-range iodine, and mainstream endocrinology recommends against supra-RDA iodine in these patients. Dermatitis herpetiformis is a specific iodine contraindication — iodine exposure can trigger or exacerbate the blistering rash. Acneiform "iododerma" can occur with chronic high-dose iodine and is a reason to stop supplementation. Pregnancy: RDA-range iodine (150–220 mcg/day) is strongly recommended given the fetal neurodevelopmental stakes, but high-dose iodine in pregnancy (above 1,100 mcg/day routinely, or certainly above 12.5 mg/day as in Lugol's) can cause fetal goiter and transient neonatal hypothyroidism and is contraindicated outside specific specialist-directed use. Breastfeeding: moderate iodine supplementation (290 mcg/day lactation RDA) is recommended; high-dose supplementation transfers to breast milk and can cause neonatal hypothyroidism. Neonates and premature infants are exquisitely iodine-sensitive and should not be exposed to povidone-iodine antiseptics on skin or mucous membranes except for specific clinical indications — topical povidone-iodine has caused iodine-induced hypothyroidism in NICU populations. Pediatric iodine supplementation should be RDA-range and pediatrician-directed. Thyroid cancer patients scheduled for I-131 ablation or scintigraphy must follow a low-iodine diet for 2–4 weeks prior and avoid all iodine-containing supplements. Patients on amiodarone (37% iodine by weight) should not take supplemental iodine; amiodarone alone already delivers pharmacologic iodine loads and thyroid dysfunction is managed through amiodarone management and endocrinology. Lithium-treated patients (both lithium and iodine suppress thyroid function) should avoid high-dose iodine and have thyroid function monitored. Shellfish allergy is not an iodine contraindication (the allergen is tropomyosin, not iodine), but IgE-mediated reactions to iodinated contrast media, povidone-iodine antiseptics (often the PVP carrier), and some topical products are real and patients with documented reactions should avoid those specific products. Drug interactions with thionamide antithyroid drugs (methimazole, PTU), radioiodine, amiodarone, and lithium are the clinically important ones. For most healthy euthyroid adults without the above risk factors, RDA-range iodine is safe and beneficial, with the cautious framework that supplementation above 1,100 mcg/day should have a specific clinical indication and endocrinology oversight. This is general educational content, not medical advice, and iodine dosing decisions in patients with thyroid disease or family history should involve an endocrinologist.
Additional Notes
Dosing iodine requires attention to both form and elemental content. Potassium iodide (KI) is 76.5% iodine by mass (one 130 mg KI tablet contains 100 mg elemental iodine — the FDA-approved radiation emergency adult dose). Sodium iodide (NaI) is 85% iodine by mass. Lugol's solution in its traditional formulation is 5% elemental iodine plus 10% potassium iodide in water, delivering approximately 6.25 mg total iodine per drop (varies by manufacturer — read the label). Iodoral tablets are Lugol's in tablet form, typically 12.5 mg or 50 mg per tablet. SSKI (saturated solution of potassium iodide) is 1 g KI/mL = 1,000 mg KI/mL = ~765 mg elemental iodine/mL = ~38 mg elemental iodine per standard drop — this is a pharmacy compound used in thyroidectomy preparation and thyroid storm, absolutely not appropriate as a routine supplement despite the similar-looking "iodine" marketing of some consumer products. Kelp supplements vary dramatically: 100–3,000 mcg per capsule depending on species (kombu highest, nori lowest) and batch, and the FDA has warned against relying on kelp for specific iodine dosing because of this variability. Standardized kelp products with third-party testing for iodine content are preferable if using food-based iodine supplements. Nascent iodine (detoxified atomic iodine) products provide typically 200–400 mcg per drop of elemental iodine and are marketed with bioavailability claims that lack robust comparative data; they are not harmful at label dosing but also not clearly superior. For RDA-range supplementation: 100–150 mcg elemental iodine/day as KI in a multivitamin or standalone prenatal. For pregnancy: target 220 mcg/day total intake, typically 150 mcg in the prenatal plus dietary iodized salt and dairy. For lactation: 290 mcg/day total. For radiation emergency: 130 mg KI for adults, following FDA/CDC dose tables for children. For Graves preoperative preparation: 5 drops SSKI three times daily for 10 days before thyroidectomy, under endocrinology direction. Timing: iodine absorption is not food-dependent and timing within the day does not affect efficacy; morning dosing with a multivitamin is fine. Iodine does not interfere with most medications in routine dosing, but can interact meaningfully with antithyroid drugs, lithium, amiodarone, and radioiodine diagnostic/therapeutic uses as detailed in the side effects section. Lab monitoring: spot urinary iodine concentration (UIC) for population-level status; 24-hour urinary iodine excretion is more accurate for individual assessment. TSH is the most important individual thyroid marker to follow when supplementing. Thyroid antibodies (TPO, TgAb) before initiating any extended iodine protocol in patients with family history of autoimmune thyroid disease or suggestive symptoms.
Frequently Asked Questions
What is the recommended Iodine dosage?
Dosage for Iodine varies by protocol. Consult a qualified healthcare provider.
How often should I take Iodine?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Iodine need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Iodine side effects?
Iodine at dietary intakes and RDA-range supplementation (150 mcg/day) is exceptionally well tolerated with essentially no side effects in healthy euthyroid people. As doses rise, the side effect profile becomes meaningful and bidirectional in a way that is unusual among nutrients. Acute high-dose iodine can trigger both iodine-induced hyperthyroidism (Jod-Basedow phenomenon) and iodine-induced hypothyroidism (Wolff-Chaikoff escape failure), sometimes in the same population but in different individuals depending on underlying thyroid status. Jod-Basedow occurs most commonly in older adults with previously undiagnosed autonomous thyroid nodules or multinodular goiter in iodine-deficient populations who suddenly get iodine repletion — these nodules have been functioning on limited substrate and hyperfunction when abundant iodine arrives. The classic presentation is new-onset palpitations, heat intolerance, weight loss, and anxiety weeks after starting iodine-containing contrast media, amiodarone, or high-dose iodine supplements. Iodine-induced hypothyroidism occurs in patients with underlying Hashimoto autoimmunity who fail to escape the Wolff-Chaikoff block, and in susceptible neonates with transient iodine-induced hypothyroidism after maternal iodine exposure. Both patterns have been documented at Lugol's and Iodoral doses (12.5–50 mg/day) in case series from Pedersen, Roti, and others. Beyond the thyroid-specific effects, acute iodine overdose (gram-level ingestion) causes GI toxicity with metallic taste, vomiting, abdominal pain, and diarrhea; chronic excess can produce "iodide mumps" (painful bilateral parotid gland swelling from iodide concentration in salivary glands), acneiform eruptions (iododerma), angioedema, and rarely severe dermatologic reactions. Iodine allergy is a medical myth with a kernel of truth — true IgE-mediated allergy to the iodine atom itself does not exist (iodine is endogenous and cannot be allergenic), but reactions to iodinated contrast media, povidone-iodine antiseptics (from the polyvinylpyrrolidone carrier, not iodine), and shellfish (from tropomyosin, not iodine content) are well-documented and frequently misattributed to iodine itself. Patients with confirmed reactions to these products should avoid the offending agents but need not avoid dietary iodine or iodized salt. In pregnancy, iodine excess (above the UL of 1,100 mcg/day for non-pregnant adults, 900 mcg/day for pregnant adults in some guidelines) can cause fetal goiter and transient neonatal hypothyroidism — this is the reason for concern about Japanese seaweed-heavy diets in pregnancy, though population data from Japan show that most Japanese pregnant women handle the higher intakes well when the gland is adapted. In breastfeeding, iodine transfers to breast milk and excessive maternal intake can cause neonatal hypothyroidism. Povidone-iodine topical antiseptic use on wounds or mucous membranes can produce measurable iodine absorption and has caused iodine-induced hypothyroidism in neonates and in premature infants particularly. Drug interactions: iodine interferes with radioactive iodine diagnostic uptake and therapy — patients scheduled for I-123 or I-131 scans or I-131 ablation must avoid iodine-containing supplements, iodized salt, seaweed, and iodine-containing contrast for 2–4 weeks prior; otherwise the test or treatment is compromised. Amiodarone (which is 37% iodine by weight) causes complex iodine-mediated thyroid dysfunction in 10–20% of chronic users and requires endocrinology monitoring. Lithium and iodine both concentrate in thyroid and can synergistically suppress thyroid function. Methimazole and propylthiouracil (thionamide antithyroid drugs) work specifically on iodine organification and are contextually relevant to any iodine dosing. Patients on thyroid hormone replacement (levothyroxine) generally tolerate normal dietary iodine but should avoid high-dose supplements without endocrinology guidance. The cleanest safety summary: at RDA-range intake (150 mcg/day, up to 220–290 mcg/day in pregnancy and lactation), iodine is extremely safe and benefits dramatically outweigh theoretical risks. Above 1,100 mcg/day (the UL), the side effect profile escalates meaningfully, especially in patients with underlying thyroid autoimmunity or autonomous nodules. Above 12.5 mg/day (Lugol's/Iodoral doses), clinically significant thyroid dysfunction in either direction becomes a realistic risk, and supplementation at these doses should not be undertaken without endocrinology involvement.
Where can I buy Iodine?
Visit our vendor directory to find trusted sources for Iodine.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
